A double-blind, randomized comparison of i.v. lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model.
about
The incidence of sub-optimal sedation in the ICU: a systematic reviewThe Sedative Effect of Propranolol on Critically Ill Patients: A Case SeriesCurrent practices of mobilization, analgesia, relaxants and sedation in Indian ICUs: A survey conducted by the Indian Society of Critical Care MedicineEffects of anesthetics, sedatives, and opioids on ventilatory control.Adverse events associated with sedatives, analgesics, and other drugs that provide patient comfort in the intensive care unit.Pharmacokinetics of intravenous lorazepam in pediatric patients with and without status epilepticusComparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients.Clinical Pharmacology Studies in Critically Ill Children.Evidence and consensus based guideline for the management of delirium, analgesia, and sedation in intensive care medicine. Revision 2015 (DAS-Guideline 2015) - short version.Economic evaluation of sustained sedation/analgesia in the intensive care unit.Treatment of Alcohol Withdrawal Syndrome with and without DexmedetomidineMedications for analgesia and sedation in the intensive care unit: an overviewScaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful?Analytic reviews: managing the agitated patient in the ICU: sedation, analgesia, and neuromuscular blockade.Sedation for critically ill or injured adults in the intensive care unit: a shifting paradigm.Effect of Modafinil on Cognitive Function in Intensive Care Unit Patients: A Retrospective Cohort Study.Reduced narcotic and sedative utilization in a NICU after implementation of pain management guidelines.The Future of Intensive Care Unit Sedation: A Report of Continuous Infusion Ketamine as an Alternative Sedative Agent.Population Pharmacokinetics and Exploratory Pharmacodynamics of Lorazepam in Pediatric Status Epilepticus.A Review of Agents for Palliative Sedation/Continuous Deep Sedation: Pharmacology and Practical Applications.Meta-analysis of hepatic cytochrome P450 ontogeny to underwrite the prediction of pediatric pharmacokinetics using physiologically based pharmacokinetic modeling.Age related inverse dose relation of sedatives and analgesics in the intensive care unit.Pharmacoeconomic modeling of lorazepam, midazolam, and propofol for continuous sedation in critically ill patients.Sedative Plasma Concentrations and Delirium Risk in Critical Illness.Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous-infusion sedatives: dexmedetomidine versus benzodiazepines.Efficacy and safety of analgosedation with fentanyl compared with traditional sedation with propofol.CYP3A5*3 and bilirubin predict midazolam population pharmacokinetics in Asian cancer patients.
P2860
Q33518901-474C0CEA-3661-450C-9B08-23A04AA9D520Q33634040-9B8FC00C-D7EC-4BB6-AB81-8E17615147EAQ34201602-548EAEEA-0902-4443-9C36-3850578B2B32Q34347573-29F5DCA5-2063-48B0-8076-73A923EDF1ABQ34419506-60F6499E-C2E3-4DFB-8A54-92AB7E972EB6Q35742520-221B13F7-ADB5-40FD-B7EE-DD0C47C42514Q35825944-0E6F18FB-2E59-48E7-8286-321B809F746EQ36120465-E3BE4AE3-4303-4C27-A668-83F4EBEC82ADQ36282065-77269209-ED9A-41C5-913F-122DF0BC937DQ36613928-1E18D924-A5E2-43B9-8F39-5F416C5D668FQ36903563-F7F1A4B6-7EAC-4C31-B484-11AC36E87AC2Q37169834-6151CED0-BF9F-4130-9763-E8BBA9DE9FD0Q37695055-43717AF8-2C8A-4066-A200-9CEF7848B6ECQ37776069-686AB64D-4E1B-449B-8B9D-939A2C64C66BQ38040844-CA2300C4-9ABE-44F9-8A5C-344441988439Q38600086-A67BBC0C-E040-45D0-A639-7C3F6A62BB9EQ38724580-7A498834-99FD-4413-866A-D1460D1C4ED9Q38872319-2C0A8B9B-1A5D-44AF-946C-DFBFA6345703Q39109020-716F1E2F-79C7-480A-8884-A8B0CAF8E0F1Q39175922-CFD624F5-FD70-4514-A840-29FE05FCFDECQ40772216-2D5CB3D2-9BA9-4CCF-9A33-FFEC1F303E13Q42366195-843397C1-0354-4F30-B49F-5FAED4FAC152Q46721363-E8101CB7-BCD5-4444-AA23-D9A27E33B008Q47552518-F223C2E1-9B38-4A04-91D4-53CC4E97A689Q47861743-1DD0F94C-3125-46DB-887E-92F2651A4B34Q47881018-6AE21990-B972-4DBF-9310-1992224D66ECQ47951996-2F007B08-87CB-4A1E-A56A-EB7B7C0B9AE6
P2860
A double-blind, randomized comparison of i.v. lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
A double-blind, randomized com ...... nts via a pharmacologic model.
@ast
A double-blind, randomized com ...... nts via a pharmacologic model.
@en
A double-blind, randomized com ...... nts via a pharmacologic model.
@nl
type
label
A double-blind, randomized com ...... nts via a pharmacologic model.
@ast
A double-blind, randomized com ...... nts via a pharmacologic model.
@en
A double-blind, randomized com ...... nts via a pharmacologic model.
@nl
prefLabel
A double-blind, randomized com ...... nts via a pharmacologic model.
@ast
A double-blind, randomized com ...... nts via a pharmacologic model.
@en
A double-blind, randomized com ...... nts via a pharmacologic model.
@nl
P2093
P1433
P1476
A double-blind, randomized com ...... nts via a pharmacologic model.
@en
P2093
P304
P356
10.1097/00000542-200108000-00007
P407
P577
2001-08-01T00:00:00Z